Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Law Firms 
Life Sciences 
High-Tech Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP Intelligence Synapse
Biopharma Intelligence Bio
Biosequence Search and Analysis Chemical
Chemical Structure Search and Analysis Eureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Patent applications for solid-state batteries surged from 302 in 2017 to 1,288 in 2025. Explore the technology routes, key players, and commercialisation timeline.
Article | Report Five proven strategies to improve tensile strength without adding weight in aerospace — from Al-Li alloys to β-titanium and topology optimisation. Data-backed analysis.
Article | Report Discover leading AI materials informatics platforms enabling closed-loop autonomous synthesis and inverse design. Find out which tools offer the best materials R&D intelligence for your needs.
Article | Report Discover leading materials informatics platforms enabling AI-driven inverse design, featuring ELN/LIMS integration. Find the best tools for your materials R&D.
Updated on March 20,2026|Written by Patsnap Team The FDA operates five distinct expedited programs for drugs and biologics addressing serious …
Updated on March 20,2026|Written by Patsnap Team Achondroplasia is the most common form of genetic short-limb dwarfism, affecting approximately 1 …
Continue reading "What Is Achondroplasia? Genetics, Clinical Features, and Emerging Treatments"
Updated on March 20,2026|Written by Patsnap Team Bruton’s tyrosine kinase (BTK) is one of the most clinically validated drug targets …
Continue reading "What Is BTK? Target Biology, Inhibitor Classes, and Clinical Applications"
Article | Report Updated on March 20, 2026 | Written by PatSnap Team Four antibody-drug conjugates (ADCs) received expedited review designations in February …
Continue reading "ADC Pipeline Update: Four Antibody-Drug Conjugates Designated in February 2026"
Updated on March 20, 2026 | Written by PatSnap Team Twelve drugs received Breakthrough Therapy designation (BTD) in February 2026 …
Continue reading "Breakthrough Therapy Designations: February 2026 Analysis"
Updated on March 20,2026|Written by Patsnap Team In February 2026, 82 drugs received expedited review designations across the US, EU, …
Continue reading "Expedited Review Pathways: 82 Drugs Designated in February 2026"
Updated on March 20,2026|Written by Patsnap Team In a single month, February 2026 delivered three KRAS-targeted regulatory events: one full …
Continue reading "KRAS G12C and G12D Inhibitors: Three Regulatory Milestones in February 2026"
Updated on March 20,2026|Written by Patsnap Team On February 9, 2026, the FDA granted Breakthrough Therapy designation to Rilzabrutinib (Sanofi) …
Continue reading " Rilzabrutinib: BTK Inhibition in Warm Autoimmune Hemolytic Anemia"
Updated on March 20,2026|Written by Patsnap Team On February 27, 2026, the FDA approved Navepegritide — branded Yuviwel — developed …
Updated on March 20,2026|Written by Patsnap Team In February 2026, Japan’s Ministry of Health, Labour and Welfare (MHLW) approved two …
Continue reading "Japan’s iPSC Cell Therapy Approvals: Two Landmark Drugs in February 2026"
Updated on March 20,2026|Written by Patsnap Team China and South Korea together accounted for 13 of the 19 global drug …
Continue reading "APAC Drug Approvals: China and South Korea, February 2026"
